Clinical Trial Update: Phase I Study of ETEC Vaccine [Phase 1]

View source ↗

Summary

A Phase I clinical trial of a vaccine targeting enterotoxigenic Escherichia coli (ETEC) has completed, evaluating safety and immunogenicity in healthy participa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Enterotoxigenic Escherichia Coli Infection

Drugs mentioned

• ETEC vaccine (Enterotoxigenic Escherichia coli vaccine)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Gastroenteritis Escherichia Coli | Phase 1 | Status: COMPLETED